Reproductive System Neoplasm, Female - Cervical Cancer

NCT02466971

Clinical Trial Information


Trial Number: NCT02466971 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Cervical Cancer
  • Reproductive System Neoplasm, Female - Vaginal Cancer
Trial Title:
"A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer"
Study ID:
NRG-GY006
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT00803062

Clinical Trial Information


Trial Number: NCT00803062 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Cervical Cancer
Trial Title:
A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865) Versus the Non-platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix
Study ID:
GOG-0240
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

NCT01672892

Clinical Trial Information


Trial Number: NCT01672892 (ClinicalTrials.gov)
Disease Type:
  • Reproductive System Neoplasm, Female - Cervical Cancer
  • Reproductive System Neoplasm, Female - Uterine Cancer
Trial Title:
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C)
Study ID:
RTOG-1203
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT01672892-D1 This dataset contains patient-reported acute toxicity and health-related quality of life (QOL) data from trial NCT01672892 to reproduce the results in PubMed ID=29989857.